查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539343

医疗影像设备市场：2024-2033年全球产业分析、规模、占有率、成长、趋势、预测

Medical Imaging Equipment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 143 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球医学影像设备市场的深入研究报告，提供了有关驱动因素、趋势、机会和挑战等市场动态的详细见解。本报告目的是提供对市场结构和未来前景的全面了解，尤其是医疗保健和医疗器材产业的利害关係人。

关键见解

  • 全球市场收入（2022年）：427亿美元
  • 预计市场价值（2033年）：648亿美元
  • 全球市场成长率（2022-2033年年复合成长率）：4.7%

全球医疗影像设备市场 - 报告范围：

医学影像设备市场涵盖了用于诊断和监测各种疾病和状况的各种设备。其中包括 X 光机、MRI 系统、超音波机、CT 扫描仪等。该市场是由对结核病、心血管疾病、骨科疾病等早期准确诊断的需求所推动的。

推动市场成长的因素：

结核病增加

结核病仍然是世界上主要的传染病之一，对医学影像设备的需求庞大，特别是在低收入和中等收入国家。根据世界卫生组织（WHO）统计，每年约有 1000万人患有结核病，每年约有 150万人死亡。大多数结核病病例集中在八个国家：孟加拉、中国、巴基斯坦、菲律宾、印尼、印度、奈及利亚和南非。这些地区结核病患者病率不断上升，推动了对 X 光和 MRI 机器的需求，这对于结核病诊断和监测非常重要。

老年人口增加

世界老年人口快速成长，尤其是在新兴市场。根据世界卫生组织估计，2019年60岁以上人口数量超过10亿，预计2030年将达到14亿，2050年将达20亿。高龄化社会更容易受到各种健康问题的影响，包括结核病和肺炎等呼吸系统疾病、骨质疏鬆症等骨科疾病以及心血管疾病。对这些疾病进行早期、准确诊断的需求推动对医学影像设备的需求。 X 光、超音波、MRI 和 CT 等技术对于诊断和管理这些与年龄相关的健康问题非常重要。

在资料管理中采用人工智慧

人工智慧（AI）与医学影像的整合彻底改变该产业。人工智慧驱动的工具提高诊断成像过程的准确性和效率，实现更好的诊断和治疗计划。医疗影像领域资料管理中人工智慧的采用预计将推动市场成长，因为它可以实现更准确的影像处理、更快的分析并改善患者的治疗结果。

产业协作与创新

医疗影像设备市场也受益于整个产业的协作和创新。例如，2022年 1月，O2 Investment Partners 将与 Modular Devices, Inc. 合作，支持该公司的发展并提供先进的诊断成像模式。这些合作预计将促进医学影像处理技术的进一步进步，使其更易于使用和有效。

市场挑战

高成本和基础设施需求

医疗影像设备市场面临的主要挑战之一是设备及其支援所需的基础设施成本高昂。 MRI 和 CT 扫描仪等先进影像技术需要大量投资，并且可能成为低收入和中等收入国家的障碍。此外，维护和操作这些设备需要专门的技能和设备，而这在某些地区可能不容易获得。

监管和合规问题

医学影像领域有严格的监管标准，以确保病患安全和设备有效性。遵守这些法规可能既复杂又耗时，特别是对于希望引进新技术或拓展新市场的公司。遵守这些法规非常重要，但它也会减缓新技术的采用并影响市场成长。

本报告解决的关键问题

  • 推动全球医学影像设备市场成长的关键因素有哪些？
  • 哪些消费族群引领进成像技术的采用？
  • 技术进步与人工智慧整合如何影响竞争格局？
  • 谁是全球医学影像设备市场的主要参与者？ 他们采取什么策略来维持市场地位？
  • 全球医学影像设备市场的新趋势与未来前景如何？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含/排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第4章 关键成功因素

  • 产品采用率分析
  • 产品 USP/特点
  • 监理状况
  • 安装基础场景
  • 最近核准的产品
  • 产品召回
  • 技术评估
  • 价值链分析
  • PESTLE分析
  • 波特的分析

第5章 市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 市场动态

第6章 COVID-19 危机分析

  • 新冠肺炎（COVID-19）与影响分析
    • 依设备
    • 依方式
    • 依最终用户
    • 依地区
  • 2024年市场情景

第7章 世界市场规模（单位）分析

  • 过去的数量（单位）分析，2019-2023年
  • 2024-2033年当前及未来数量（单位）预测
    • 年成长趋势分析
    • 绝对数量机会分析

第8章 世界市场 - 价格分析

  • 区域价格分析：依产品分类
  • 价格明细
    • 製造商等级定价
    • 经销商级定价
  • 世界平均价格分析基准
  • 定价假设

第9章 全球市场需求（10亿美元）分析

  • 过去市场价值分析（十亿美元），2019-2023
  • 2024-2033年当前和未来市场价值（十亿美元）的分析和预测
    • 年成长趋势分析
    • 绝对数量机会分析

第10章 世界市场分析：按设备

  • 简介/主要发现
  • 2019-2023年历史市场规模（十亿美元）和数量（单位）分析：按设备
  • 2024-2033年当前和未来市场规模（十亿美元）和数量（单位）的分析和预测：按设备
    • 电脑断层扫描（CT）系统
    • X射线系统
    • 核磁共振系统
    • 超音波系统
    • 核子造影装置
    • 乳房X光检查设备
    • 造影剂注射器
    • C 型臂/透视装置
  • 市场吸引力分析：依设备分类

第11章 全球市场分析：按模式

  • 简介/主要发现
  • 历史市场规模（十亿美元）分析：依模式，2019-2023年
  • 2024-2033年当前和未来市场规模（十亿美元）的分析和预测：依模式
    • 独立设备
    • 携带式设备
    • 手持设备
  • 市场吸引力分析：依方式分类

第12章 世界市场分析：依最终用户

  • 简介/主要发现
  • 历史市场规模（十亿美元）分析：依最终用户，2019-2023年
  • 2024-2033年当前和未来市场规模（十亿美元）的分析和预测：依最终用户
    • 影像诊断中心
    • 门诊手术中心
    • 专科诊所
    • 调查机构
  • 市场吸引力分析：依最终用户分类

第13章 世界市场分析：依地区

  • 简介
  • 2019-2023年过往市场规模（十亿美元）和数量（单位）分析：依地区
  • 2024-2033年当前和未来市场价值（十亿美元）和数量（单位）的分析和预测：依地区
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲（MEA）
  • 市场吸引力分析：依地区

第14章 北美市场分析

第15章 拉丁美洲市场分析

第16章 欧洲市场分析

第17章 东亚市场分析

第18章 南亚市场分析

第19章 大洋洲市场

第20章 中东与非洲（MEA）市场分析

第21章 市场结构分析

  • 市场分析：依公司层级
  • 主要公司市占率分析
  • 市场现况分析

第22章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争详情
    • GE Healthcare
    • Hitachi Medical Corporation
    • Philips Healthcare
    • Siemens Healthineers
    • Toshiba Medical Systems Corporation
    • Esaote SpA
    • Positron Corporation
    • Neusoft Medical Systems
    • Neurologica Corporation
    • Mediso Medical Imaging Systems
    • Digirad
    • SHIMADZU CORPORATION
    • Hologic, Inc.
    • Guerbet SA
    • Bayer AG
    • Mallinckrodt
    • Bracco Imaging SpA
    • Ulrich GmbH &Co. KG
    • Medtron
    • Nemoto Kyorindo Co. Ltd
    • Lemer Pax

第23章 使用的先决条件与缩写

第24章 研究方法

简介目录
Product Code: PMRREP11215

Persistence Market Research has recently published an in-depth report on the global medical imaging equipment market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a comprehensive understanding of the market structure and future outlook, particularly for stakeholders in the healthcare and medical device industries.

Key Insights:

  • Global Market Revenue (2022): US$ 42.7 Billion
  • Estimated Market Value (2033): US$ 64.8 Billion
  • Global Market Growth Rate (CAGR 2022-2033): 4.7%

Global Medical Imaging Equipment Market - Report Scope:

The medical imaging equipment market covers a broad range of devices used in the diagnosis and monitoring of various diseases and conditions. These include X-ray machines, MRI systems, ultrasound devices, and CT scanners. The market is driven by the need for early and accurate diagnosis, particularly for conditions like tuberculosis, cardiovascular diseases, and orthopedic disorders.

Market Growth Drivers:

Growing Incidences of Tuberculosis (TB)

Tuberculosis (TB) remains one of the leading infectious diseases globally, with significant demand for medical imaging equipment, particularly in low- and middle-income countries. According to the World Health Organization (WHO), around 10 million people develop TB annually, with the disease claiming approximately 1.5 million lives each year. The majority of TB cases are concentrated in eight countries, including Bangladesh, China, Pakistan, the Philippines, Indonesia, India, Nigeria, and South Africa. The rising prevalence of TB in these regions is driving the demand for X-ray and MRI equipment, which are crucial for diagnosing and monitoring the disease.

Rising Geriatric Population

The global geriatric population is increasing at a rapid pace, particularly in emerging markets. According to WHO estimates, there were over 1 billion people aged 60 and above in 2019, with this number expected to reach 1.4 billion by 2030 and 2 billion by 2050. The aging population is more susceptible to a range of health issues, including respiratory diseases (such as tuberculosis and pneumonia), orthopedic conditions (like osteoporosis), and cardiovascular diseases. The need for early and accurate diagnosis of these conditions is driving demand for medical imaging equipment. Technologies such as X-ray, ultrasound, MRI, and CT are essential for diagnosing and managing these age-related health issues.

Adoption of AI in Data Management

The integration of artificial intelligence (AI) into medical imaging is revolutionizing the industry. AI-driven tools are enhancing the accuracy and efficiency of imaging processes, enabling better diagnosis and treatment planning. The adoption of AI in data management within the medical imaging sector is expected to drive market growth, as it allows for more precise imaging, faster analysis, and improved patient outcomes.

Industry Collaborations and Innovations

The medical imaging equipment market is also benefiting from industry-wide collaborations and innovations. For instance, in January 2022, O2 Investment Partners collaborated with Modular Devices, Inc. to support the company's growth and provide advanced imaging modalities. Such partnerships are expected to drive further advancements in medical imaging technology, making it more accessible and effective.

Market Challenges:

High Costs and Infrastructure Requirements

One of the significant challenges facing the medical imaging equipment market is the high cost of devices and the infrastructure needed to support them. Advanced imaging technologies such as MRI and CT scanners require substantial investment, which can be a barrier in low- and middle-income countries. Additionally, the maintenance and operation of these devices require specialized skills and facilities, which may not be readily available in all regions.

Regulatory and Compliance Issues

The medical imaging sector is subject to strict regulatory standards to ensure patient safety and device efficacy. Navigating these regulations can be complex and time-consuming, particularly for companies looking to introduce new technologies or expand into new markets. Compliance with these regulations is essential, but it can also slow down the adoption of new technologies and impact market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global medical imaging equipment market?
  • Which consumer segments are leading the adoption of advanced imaging technologies?
  • How are technological advancements and AI integration influencing the competitive landscape?
  • Who are the key players in the global medical imaging equipment market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global medical imaging equipment market?

Competitive Intelligence and Business Strategy:

Leading players in the global medical imaging equipment market, such as Siemens Healthineers, GE Healthcare, and Philips Healthcare, are focusing on product innovation, strategic collaborations, and expanding their presence in emerging markets. These companies are investing heavily in research and development to create advanced imaging technologies that offer enhanced diagnostic capabilities and better patient outcomes. Partnerships and collaborations are also playing a key role in driving innovation and expanding the reach of these technologies globally.

Key Companies Profiled:

  • GE Healthcare
  • Hitachi Medical Corporation
  • Philips Healthcare
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation
  • Esaote S.p.A
  • Positron Corporation
  • Neusoft Medical Systems
  • Neurologica Corporation
  • Mediso Medical Imaging Systems
  • Digirad
  • SHIMADZU CORPORATION
  • Hologic, Inc.
  • Guerbet SA
  • Bayer AG
  • Mallinckrodt
  • Bracco Imaging S.p.A
  • Ulrich GmbH & Co. KG
  • Medtron
  • Nemoto Kyorindo Co. Ltd
  • Lemer Pax

Key Segments Covered in Medical Imaging Equipment Industry Research

Equipment:

  • Computed Tomography (CT) Systems
  • X-ray Systems
  • MRI Systems
  • Ultrasound Systems
  • Nuclear Imaging Equipment
  • Mammography Equipment
  • Contrast Media Injectors
  • C-Arms & Fluoroscopy Devices

Modality:

  • Stand-Alone Devices
  • Portable Devices
  • Hand-Held Devices

End User:

  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Product USPs/ Features
  • 4.3. Regulatory Landscape
  • 4.4. Install Base Scenario
  • 4.5. Recent Product Approved
  • 4.6. Product Recall
  • 4.7. Technology Assessment
  • 4.8. Value Chain Analysis
  • 4.9. PESTLE Analysis
  • 4.10. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Medical Devices Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising incidence of chronic diseases
    • 5.2.2. Rising Demand in Emerging Economies for Imaging Technologies
    • 5.2.3. Growing Advancements in Maneuverability and Imaging Capabilities
    • 5.2.4. Adoption of alternative techniques
    • 5.2.5. Strategic mergers and acquisitions
    • 5.2.6. Favorable Reimbursement scenario
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Equipment
    • 6.1.2. By Modality
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Volume (in Units) Analysis, 2019-2023
  • 7.2. Current and Future Volume (in Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Equipment

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Equipment, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Equipment, 2024-2033
    • 10.3.1. Computed Tomography (CT) Systems
      • 10.3.1.1. 256-320 slice CT Systems
      • 10.3.1.2. 128-slice CT Systems
      • 10.3.1.3. 64-slice CT Systems
      • 10.3.1.4. 16-slice and below CT Systems
    • 10.3.2. X-ray Systems
      • 10.3.2.1. Analog X-ray Systems
      • 10.3.2.2. Digital X-ray Systems
        • 10.3.2.2.1. Computed Radiography (CR) Systems
        • 10.3.2.2.2. Digital Radiography (DR) Systems
        • 10.3.2.2.3. Retrofit X-ray Systems
    • 10.3.3. MRI Systems
      • 10.3.3.1. 0.7 T MRI Systems
      • 10.3.3.2. 1.5 T MRI Systems
      • 10.3.3.3. 3 T MRI Systems
      • 10.3.3.4. 7 T MRI Systems
      • 10.3.3.5. Others
    • 10.3.4. Ultrasound Systems
      • 10.3.4.1. Black & White Ultrasound Systems
      • 10.3.4.2. Color Doppler Ultrasound Systems
    • 10.3.5. Nuclear Imaging Equipment
      • 10.3.5.1. Positron Emission Tomography (PET) Systems
        • 10.3.5.1.1. PET Scanners
        • 10.3.5.1.2. PET/CT
        • 10.3.5.1.3. PET/MRI
      • 10.3.5.2. Single-Photon Emission Computed Tomography
        • 10.3.5.2.1. Single Imaging Gamma Cameras
        • 10.3.5.2.2. SPECT/CT
    • 10.3.6. Mammography Equipment
      • 10.3.6.1. Film-Screen Mammography Equipment
      • 10.3.6.2. 2D Digital Mammography Equipment
      • 10.3.6.3. 3D Tomosynthesis
    • 10.3.7. Contrast Media Injectors
      • 10.3.7.1. CT Injectors
      • 10.3.7.2. MRI Injectors
      • 10.3.7.3. Cardio Injectors
      • 10.3.7.4. PET Injectors
    • 10.3.8. C-Arms & Fluoroscopy Devices
      • 10.3.8.1. C-Arms Systems
        • 10.3.8.1.1. Full Size C - arms Systems
        • 10.3.8.1.2. Mini C - arms Systems
      • 10.3.8.2. Fluoroscopy Devices
  • 10.4. Market Attractiveness Analysis, by Equipment

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Modality, 2024-2033
    • 11.3.1. Stand-Alone Devices
    • 11.3.2. Portable Devices
    • 11.3.3. Hand-Held Devices
  • 11.4. Market Attractiveness Analysis, by Modality

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
    • 12.3.1. Diagnostic Imaging Centers
    • 12.3.2. Ambulatory Surgical Centers
    • 12.3.3. Specialty Clinics
    • 12.3.4. Research Institutes
  • 12.4. Market Attractiveness Analysis, by End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis, by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Equipment
    • 14.3.3. By Modality
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Equipment
    • 14.4.3. By Modality
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Equipment
        • 14.7.1.2.2. By Modality
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Equipment
        • 14.7.2.2.2. By Modality
        • 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Equipment
    • 15.3.3. By Modality
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Equipment
    • 15.4.3. By Modality
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Mexico Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Equipment
        • 15.7.1.2.2. By Modality
        • 15.7.1.2.3. By End User
    • 15.7.2. Brazil Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Equipment
        • 15.7.2.2.2. By Modality
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Equipment
        • 15.7.3.2.2. By Modality
        • 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. BENELUX
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Equipment
    • 16.3.3. By Modality
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Equipment
    • 16.4.3. By Modality
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Equipment
        • 16.7.1.2.2. By Modality
        • 16.7.1.2.3. By End User
    • 16.7.2. Italy Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Equipment
        • 16.7.2.2.2. By Modality
        • 16.7.2.2.3. By End User
    • 16.7.3. France Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Equipment
        • 16.7.3.2.2. By Modality
        • 16.7.3.2.3. By End User
    • 16.7.4. U.K. Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Equipment
        • 16.7.4.2.2. By Modality
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Market Analysis
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.5.2.1. By Equipment
        • 16.7.5.2.2. By Modality
        • 16.7.5.2.3. By End User
    • 16.7.6. Russia Market Analysis
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.6.2.1. By Equipment
        • 16.7.6.2.2. By Modality
        • 16.7.6.2.3. By End User
    • 16.7.7. BENELUX Market Analysis
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.7.2.1. By Equipment
        • 16.7.7.2.2. By Modality
        • 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Equipment
    • 17.3.3. By Modality
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Equipment
    • 17.4.2. By Modality
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. China Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Equipment
        • 17.7.1.2.2. By Modality
        • 17.7.1.2.3. By End User
    • 17.7.2. Japan Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Equipment
        • 17.7.2.2.2. By Modality
        • 17.7.2.2.3. By End User
    • 17.7.3. South Korea Market Analysis
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.3.2.1. By Equipment
        • 17.7.3.2.2. By Modality
        • 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Equipment
    • 18.3.3. By Modality
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Equipment
    • 18.4.3. By Modality
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. India Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Equipment
        • 18.7.1.2.2. By Modality
        • 18.7.1.2.3. By End User
    • 18.7.2. Indonesia Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Equipment
        • 18.7.2.2.2. By Modality
        • 18.7.2.2.3. By End User
    • 18.7.3. Malaysia Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Equipment
        • 18.7.3.2.2. By Modality
        • 18.7.3.2.3. By End User
    • 18.7.4. Thailand Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Equipment
        • 18.7.4.2.2. By Modality
        • 18.7.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Equipment
    • 19.3.3. By Modality
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Equipment
    • 19.4.3. By Modality
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Market Analysis
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.7.1.2.1. By Equipment
        • 19.7.1.2.2. By Modality
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Market Analysis
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.7.2.2.1. By Equipment
        • 19.7.2.2.2. By Modality
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Equipment
    • 20.3.3. By Modality
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Equipment
    • 20.4.2. By Modality
    • 20.4.3. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Market Analysis
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.1.2.1. By Equipment
        • 20.7.1.2.2. By Modality
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkiye Market Analysis
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.2.2.1. By Equipment
        • 20.7.2.2.2. By Modality
        • 20.7.2.2.3. By End User
    • 20.7.3. South Africa Market Analysis
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.3.2.1. By Equipment
        • 20.7.3.2.2. By Modality
        • 20.7.3.2.3. By End User
    • 20.7.4. North Africa Market Analysis
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.4.2.1. By Equipment
        • 20.7.4.2.2. By Modality
        • 20.7.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis, by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. GE Healthcare
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Financials
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Strategy Overview
        • 22.3.1.6.1. Marketing Strategy
        • 22.3.1.6.2. Product Strategy
        • 22.3.1.6.3. Channel Strategy
    • 22.3.2. Hitachi Medical Corporation
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Financials
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Strategy Overview
        • 22.3.2.6.1. Marketing Strategy
        • 22.3.2.6.2. Product Strategy
        • 22.3.2.6.3. Channel Strategy
    • 22.3.3. Philips Healthcare
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Financials
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Strategy Overview
        • 22.3.3.6.1. Marketing Strategy
        • 22.3.3.6.2. Product Strategy
        • 22.3.3.6.3. Channel Strategy
    • 22.3.4. Siemens Healthineers
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Financials
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Strategy Overview
        • 22.3.4.6.1. Marketing Strategy
        • 22.3.4.6.2. Product Strategy
        • 22.3.4.6.3. Channel Strategy
    • 22.3.5. Toshiba Medical Systems Corporation
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Financials
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Strategy Overview
        • 22.3.5.6.1. Marketing Strategy
        • 22.3.5.6.2. Product Strategy
        • 22.3.5.6.3. Channel Strategy
    • 22.3.6. Esaote S.p.A
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Financials
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Strategy Overview
        • 22.3.6.6.1. Marketing Strategy
        • 22.3.6.6.2. Product Strategy
        • 22.3.6.6.3. Channel Strategy
    • 22.3.7. Positron Corporation
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Financials
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Strategy Overview
        • 22.3.7.6.1. Marketing Strategy
        • 22.3.7.6.2. Product Strategy
        • 22.3.7.6.3. Channel Strategy
    • 22.3.8. Neusoft Medical Systems
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Financials
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Strategy Overview
        • 22.3.8.6.1. Marketing Strategy
        • 22.3.8.6.2. Product Strategy
        • 22.3.8.6.3. Channel Strategy
    • 22.3.9. Neurologica Corporation
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Financials
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Strategy Overview
        • 22.3.9.6.1. Marketing Strategy
        • 22.3.9.6.2. Product Strategy
        • 22.3.9.6.3. Channel Strategy
    • 22.3.10. Mediso Medical Imaging Systems
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Financials
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Strategy Overview
        • 22.3.10.6.1. Marketing Strategy
        • 22.3.10.6.2. Product Strategy
        • 22.3.10.6.3. Channel Strategy
    • 22.3.11. Digirad
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Sales Footprint
      • 22.3.11.4. Key Financials
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Strategy Overview
        • 22.3.11.6.1. Marketing Strategy
        • 22.3.11.6.2. Product Strategy
        • 22.3.11.6.3. Channel Strategy
    • 22.3.12. SHIMADZU CORPORATION
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Sales Footprint
      • 22.3.12.4. Key Financials
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Strategy Overview
        • 22.3.12.6.1. Marketing Strategy
        • 22.3.12.6.2. Product Strategy
        • 22.3.12.6.3. Channel Strategy
    • 22.3.13. Hologic, Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Sales Footprint
      • 22.3.13.4. Key Financials
      • 22.3.13.5. SWOT Analysis
      • 22.3.13.6. Strategy Overview
        • 22.3.13.6.1. Marketing Strategy
        • 22.3.13.6.2. Product Strategy
        • 22.3.13.6.3. Channel Strategy
    • 22.3.14. Guerbet SA
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Sales Footprint
      • 22.3.14.4. Key Financials
      • 22.3.14.5. SWOT Analysis
      • 22.3.14.6. Strategy Overview
        • 22.3.14.6.1. Marketing Strategy
        • 22.3.14.6.2. Product Strategy
        • 22.3.14.6.3. Channel Strategy
    • 22.3.15. Bayer AG
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Sales Footprint
      • 22.3.15.4. Key Financials
      • 22.3.15.5. SWOT Analysis
      • 22.3.15.6. Strategy Overview
        • 22.3.15.6.1. Marketing Strategy
        • 22.3.15.6.2. Product Strategy
        • 22.3.15.6.3. Channel Strategy
    • 22.3.16. Mallinckrodt
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Sales Footprint
      • 22.3.16.4. Key Financials
      • 22.3.16.5. SWOT Analysis
      • 22.3.16.6. Strategy Overview
        • 22.3.16.6.1. Marketing Strategy
        • 22.3.16.6.2. Product Strategy
        • 22.3.16.6.3. Channel Strategy
    • 22.3.17. Bracco Imaging S.p.A
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Sales Footprint
      • 22.3.17.4. Key Financials
      • 22.3.17.5. SWOT Analysis
      • 22.3.17.6. Strategy Overview
        • 22.3.17.6.1. Marketing Strategy
        • 22.3.17.6.2. Product Strategy
        • 22.3.17.6.3. Channel Strategy
    • 22.3.18. Ulrich GmbH & Co. KG
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Sales Footprint
      • 22.3.18.4. Key Financials
      • 22.3.18.5. SWOT Analysis
      • 22.3.18.6. Strategy Overview
        • 22.3.18.6.1. Marketing Strategy
        • 22.3.18.6.2. Product Strategy
        • 22.3.18.6.3. Channel Strategy
    • 22.3.19. Medtron
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Sales Footprint
      • 22.3.19.4. Key Financials
      • 22.3.19.5. SWOT Analysis
      • 22.3.19.6. Strategy Overview
        • 22.3.19.6.1. Marketing Strategy
        • 22.3.19.6.2. Product Strategy
        • 22.3.19.6.3. Channel Strategy
    • 22.3.20. Nemoto Kyorindo Co. Ltd
      • 22.3.20.1. Overview
      • 22.3.20.2. Product Portfolio
      • 22.3.20.3. Sales Footprint
      • 22.3.20.4. Key Financials
      • 22.3.20.5. SWOT Analysis
      • 22.3.20.6. Strategy Overview
        • 22.3.20.6.1. Marketing Strategy
        • 22.3.20.6.2. Product Strategy
        • 22.3.20.6.3. Channel Strategy
    • 22.3.21. Lemer Pax
      • 22.3.21.1. Overview
      • 22.3.21.2. Product Portfolio
      • 22.3.21.3. Sales Footprint
      • 22.3.21.4. Key Financials
      • 22.3.21.5. SWOT Analysis
      • 22.3.21.6. Strategy Overview
        • 22.3.21.6.1. Marketing Strategy
        • 22.3.21.6.2. Product Strategy
        • 22.3.21.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology